A1A535
Gene name |
Veph1 (Veph) |
Protein name |
Ventricular zone-expressed PH domain-containing protein 1 |
Names |
Protein melted homolog |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:72789 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for A1A535
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-A1A535-F1 | Predicted | AlphaFoldDB |
37 variants for A1A535
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3393166758 | 9 | L>F | No | EVA | |
| rs3392942770 | 11 | Q>P | No | EVA | |
| rs3388635171 | 41 | V>E | No | EVA | |
| rs3388636588 | 87 | D>G | No | EVA | |
| rs3388622182 | 92 | H>Y | No | EVA | |
| rs3388634595 | 208 | S>T | No | EVA | |
| rs3388615062 | 231 | V>E | No | EVA | |
| rs3388626701 | 256 | N>Y | No | EVA | |
| rs3388622144 | 289 | Q>L | No | EVA | |
| rs3388633975 | 340 | S>F | No | EVA | |
| rs235022309 | 393 | N>K | No | EVA | |
| rs216573640 | 396 | E>K | No | EVA | |
| rs31512068 | 460 | V>M | No | EVA | |
| rs3388634676 | 469 | E>D | No | EVA | |
| rs3388632562 | 470 | K>M | No | EVA | |
| rs236120073 | 475 | A>V | No | EVA | |
| rs36271080 | 500 | G>E | No | EVA | |
| rs255242982 | 516 | T>I | No | EVA | |
| rs232051022 | 523 | E>K | No | EVA | |
| rs3388632179 | 528 | N>H | No | EVA | |
| rs3392941777 | 538 | T>S | No | EVA | |
| rs30404479 | 541 | I>V | No | EVA | |
| rs3393108118 | 561 | Y>* | No | EVA | |
| rs245102252 | 607 | I>T | No | EVA | |
| rs227699500 | 619 | V>I | No | EVA | |
| rs3388630349 | 631 | P>S | No | EVA | |
| rs3388638049 | 639 | V>M | No | EVA | |
| rs3388634701 | 656 | S>G | No | EVA | |
| rs3388630780 | 667 | P>S | No | EVA | |
| rs3388628657 | 688 | F>LR* | No | EVA | |
| rs3388625147 | 691 | S>R | No | EVA | |
| rs3388628297 | 722 | K>T | No | EVA | |
| rs3388638031 | 725 | E>G | No | EVA | |
| rs13477164 | 739 | H>R | No | EVA | |
| rs223461791 | 762 | S>P | No | EVA | |
| rs3388632514 | 776 | A>T | No | EVA | |
| rs3388615082 | 821 | A>T | No | EVA |
No associated diseases with A1A535
1 regional properties for A1A535
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Pleckstrin homology domain | 716 - 821 | IPR001849 |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| phosphatidylinositol-5-phosphate binding | Binding to phosphatidylinositol-5-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 5' position. |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of SMAD protein signal transduction | Any process that decreases the rate, frequency or extent of the SMAD protein signaling pathway. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
| negative regulation of transforming growth factor beta receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway. |
| regulation of signal transduction | Any process that modulates the frequency, rate or extent of signal transduction. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MHQLFRLVLG | QKDLSKAGDL | FSLDDAEIED | SLTEALEQIK | VISSSLDYQT | NNNDQAVVEI |
| 70 | 80 | 90 | 100 | 110 | 120 |
| CITRITTAIR | ETESIEKHAR | ALVGLWDSCL | EHNLRPAGKD | EDTPHAKIAS | DIMSCILQNY |
| 130 | 140 | 150 | 160 | 170 | 180 |
| NRTPVMVLAV | PIAVKFLHRG | SKELCRNMSN | YLSLAAITKA | DLLADHTEGI | IKSILQGNAM |
| 190 | 200 | 210 | 220 | 230 | 240 |
| LLRVLPAVYE | KQPQPINRHL | AELLALMSQL | EQTEQYHLLR | LLHVAAKRKD | VEVVQKCVPF |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LIRNLKDSTY | NDIILNILIE | IAGHEPLALN | SFLPMLKEIA | EQFPYLTGQM | ARIFGAVGHV |
| 310 | 320 | 330 | 340 | 350 | 360 |
| DEERARSCLR | YLVSQLANME | HPFHHILLLE | IKSITDAFSS | ILGPHSRDIF | RMSNSFTNIA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| KLLSRQLENS | KADSSRRKTS | TEVSIPEKLR | ELNSMEPESE | DHEKLQVKIQ | AFEDKINAES |
| 430 | 440 | 450 | 460 | 470 | 480 |
| NTPGSGRRYS | LDHISKEERK | SIRFSRSRSL | ALNTVLTNGV | SVEDNEVEEK | AGMHASISLS |
| 490 | 500 | 510 | 520 | 530 | 540 |
| QIDPLSHGIG | KLPFKTDTHG | SPLRNSSASH | PSIIHTEPET | MPETFKENIQ | EEILEAATSP |
| 550 | 560 | 570 | 580 | 590 | 600 |
| IEYQDKLYLH | LRENLSKVKA | YALEIAKKVP | IPDQCTIEDT | MRSCVAKLFF | TCSLKGHYCL |
| 610 | 620 | 630 | 640 | 650 | 660 |
| YSKSSFILVS | QAPQPWIQVM | FLSQQSLFPE | PLSIQSGSVQ | FLKALWEKTQ | DTGAHSFEVA |
| 670 | 680 | 690 | 700 | 710 | 720 |
| MTESTFPQQK | DLEQLQLHLE | EVRFFDVFGF | SETAGAWQCF | MCNNPEKATV | VNQDGQPLIE |
| 730 | 740 | 750 | 760 | 770 | 780 |
| GKLKEKQVRW | KFIKRWKTHY | FTLAGNQLLF | QKGKSKDDPD | DSPIELSKVQ | SVKAVAKKRR |
| 790 | 800 | 810 | 820 | 830 | |
| DRSLPRAFEI | FTDSKTYVFK | AKDEKNAEEW | LQCINVALAQ | AKERESREVT | TYL |